Literature DB >> 33206137

Looking to Long-term Survivors for Improved Pancreatic Cancer Treatment.

Bridget M Kuehn.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 33206137     DOI： 10.1001/jama.2020.21717

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  11 in total

1.  Genetic landscape of pancreatic adenocarcinoma patients: a pilot study from Pakistan.

Authors:  Saleema Mehboob Ali; Yumna Adnan; Zubair Ahmad; Hasnain Ahmed Farooqui; Tabish Chawla; S M Adnan Ali
Journal:  Mol Biol Rep       Date:  2021-11-23       Impact factor: 2.316

2.  PD-L1 correlated gene expression profiles and tumor infiltrating lymphocytes in pancreatic cancer.

Authors:  Jiajin Li; Lu Yin; Yumei Chen; Shuxian An; Yi Xiong; Gang Huang; Jianjun Liu
Journal:  Int J Med Sci       Date:  2021-07-05       Impact factor: 3.738

Review 3.  Targeting the Endocannabinoidome in Pancreatic Cancer.

Authors:  Valerio Falasca; Marco Falasca
Journal:  Biomolecules       Date:  2022-02-17

Review 4.  An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer.

Authors:  Maryum Nisar; Rehan Zafar Paracha; Sidra Adil; Sumair Naseem Qureshi; Hussnain Ahmed Janjua
Journal:  Front Oncol       Date:  2022-05-24       Impact factor: 5.738

Review 5.  Tumor-Stroma Interaction in PDAC as a New Approach for Liquid Biopsy and its Potential Clinical Implications.

Authors:  Julian Götze; Christine Nitschke; Faik G Uzunoglu; Klaus Pantel; Marianne Sinn; Harriet Wikman
Journal:  Front Cell Dev Biol       Date:  2022-05-26

6.  Identifying and Validating an Acidosis-Related Signature Associated with Prognosis and Tumor Immune Infiltration Characteristics in Pancreatic Carcinoma.

Authors:  Pingfei Tang; Weiming Qu; Dajun Wu; Shihua Chen; Minji Liu; Weishun Chen; Qiongjia Ai; Haijuan Tang; Hongbing Zhou
Journal:  J Immunol Res       Date:  2021-12-28       Impact factor: 4.818

7.  Interaction Analysis of Adenovirus L5 Protein With Pancreatic Cancer Cell Surface Receptor to Analyze Its Affinity for Oncolytic Virus Therapy.

Authors:  Maryum Nisar; Rehan Zafar Paracha; Alvina Gul; Iqra Arshad; Saima Ejaz; Didar Murad; Shahzeb Khan; Zartasha Mustansar
Journal:  Front Oncol       Date:  2022-03-10       Impact factor: 6.244

8.  TIPE3 is a candidate prognostic biomarker promoting tumor progression via elevating RAC1 in pancreatic cancer.

Authors:  Zequn Li; Shougen Cao; Yuqi Sun; Zhaojian Niu; Xiaodong Liu; Jun Niu; Yanbing Zhou
Journal:  Mol Cancer       Date:  2022-08-09       Impact factor: 41.444

Review 9.  The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives.

Authors:  Shun Wang; Yan Zheng; Feng Yang; Le Zhu; Xiao-Qiang Zhu; Zhe-Fang Wang; Xiao-Lin Wu; Cheng-Hui Zhou; Jia-Yan Yan; Bei-Yuan Hu; Bo Kong; De-Liang Fu; Christiane Bruns; Yue Zhao; Lun-Xiu Qin; Qiong-Zhu Dong
Journal:  Signal Transduct Target Ther       Date:  2021-07-05

Review 10.  The significance of exosomal RNAs in the development, diagnosis, and treatment of pancreatic cancer.

Authors:  Zheng Zhao; Guiping Zhao; Shuyue Yang; Shengtao Zhu; Shutian Zhang; Peng Li
Journal:  Cancer Cell Int       Date:  2021-07-09       Impact factor: 5.722
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.